Page 15 - ANWITA DEVELOPMENT TO TT
P. 15
DEVELOPED & COMMERCIALISED
PRODUCT LIST (Cont.)
Active ingredients Dose or % of strength Pharmaceutical Dosage Form Therapeutic Area
IRBESARTAN 50% AND HYDROCHLORTHIAZIDE 4.16% GRANULES Tablet & Capsule
IRBESARTAN 50% GRANULES Tablet & Capsule
METOPROLOL SUCCINATE 10% GRANULES 10% 20% 25% 50% 29.5% Tablet & Capsule
OLMESARTAN MEDOXOMIL 13.33 % AND AMLODIPINE 1.67% AND Tablet & Capsule
HYDROCHLOROTHIAZIDE 4.17% GRANULES
OLMESARTAN MEDOXOMIL 13.33 % AND AMLODIPINE 1.67% GRANULES Tablet & Capsule
OLMESARTAN MEDOXOMIL 13.33 % AND AMLODIPINE 3.34% GRANULES Tablet & Capsule
OLMESARTAN MEDOXOMIL 13.33 % AND HYDROCHLOROTHIAZIDE 4.17% Tablet & Capsule
GRANULES
